• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

TAMS names new president

Article

Japanese multimodality vendor Toshiba this month appointed Hiromitsu Igarashi as president of the company’s U.S. operation, Toshiba America Medical Systems, of Tustin, CA. Igarashi replaces Masamichi Katsurada, who has served as president of

Japanese multimodality vendor Toshiba this month appointed Hiromitsu Igarashi as president of the company’s U.S. operation, Toshiba America Medical Systems, of Tustin, CA. Igarashi replaces Masamichi Katsurada, who has served as president of TAMS since 1996. Katsurada has been named to the post of vice president of Toshiba Medical Systems and will return to Japan.

Igarashi brings experience in the U.S. market to his new post from his two-year stint as president of South San Francisco, CA-based Toshiba America MRI. During his time at TAMI, Igarashi oversaw the global launch of Opart, Toshiba’s 0.35-tesla MRI system. Some 200 Oparts have been installed worldwide (SCAN 12/18/96).

© 1999 Miller Freeman, Inc.All rights reserved.

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.